Ipswich Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,865
| Closed | -$483K | – | 181 |
|
|
2019
Q3 | $483K | Sell |
4,865
-255
| -5% | -$24.2K | 0.15% | 118 |
|
|
2019
Q2 | $473K | Sell |
5,120
-50
| -1% | -$4.75K | 0.15% | 118 |
|
|
2019
Q1 | $488K | Sell |
5,170
-485
| -9% | -$42.4K | 0.16% | 115 |
|
|
2018
Q4 | $362K | Sell |
5,655
-625
| -10% | -$46.1K | 0.13% | 120 |
|
|
2018
Q3 | $562K | Buy |
+6,280
| New | +$555K | 0.19% | 102 |
|
|
2018
Q2 | – | Sell |
-16,179
| Closed | -$1.44M | – | 155 |
|
|
2018
Q1 | $1.44M | Sell |
16,179
-1,609
| -9% | -$154K | 0.61% | 51 |
|
|
2017
Q4 | $1.86M | Sell |
17,788
-8,685
| -33% | -$980K | 0.79% | 41 |
|
|
2017
Q3 | $3.86M | Buy |
26,473
+70
| +0.3% | +$9.54K | 1.73% | 20 |
|
|
2017
Q2 | $3.43M | Sell |
26,403
-2,195
| -8% | -$269K | 1.61% | 21 |
|
|
2017
Q1 | $3.56M | Buy |
28,598
+1,040
| +4% | +$124K | 1.55% | 24 |
|
|
2016
Q4 | $3.19M | Buy |
27,558
+2,433
| +10% | +$271K | 1.44% | 24 |
|
|
2016
Q3 | $2.63M | Sell |
25,125
-52
| -0.2% | -$5.63K | 1.28% | 28 |
|
|
2016
Q2 | $2.48M | Buy |
25,177
+315
| +1% | +$32.6K | 1.23% | 32 |
|
|
2016
Q1 | $2.55M | Sell |
24,862
-3,878
| -13% | -$399K | 1.21% | 32 |
|
|
2015
Q4 | $3.44M | Buy |
28,740
+2,215
| +8% | +$256K | 1.55% | 22 |
|
|
2015
Q3 | $2.87M | Buy |
26,525
+1,535
| +6% | +$190K | 1.37% | 29 |
|
|
2015
Q2 | $2.89M | Sell |
24,990
-1,520
| -6% | -$174K | 1.3% | 31 |
|
|
2015
Q1 | $3.06M | Sell |
26,510
-1,310
| -5% | -$157K | 1.34% | 28 |
|
|
2014
Q4 | $3.11M | Buy |
27,820
+80
| +0.3% | +$8.44K | 1.33% | 31 |
|
|
2014
Q3 | $2.63M | Sell |
27,740
-280
| -1% | -$25.3K | 1.12% | 38 |
|
|
2014
Q2 | $2.41M | Buy |
28,020
+6,410
| +30% | +$487K | 0.93% | 45 |
|
|
2014
Q1 | $1.51M | Buy |
21,610
+17,560
| +434% | +$1.39M | 0.65% | 50 |
|
|
2013
Q4 | $342K | Buy |
4,050
+650
| +19% | +$51.4K | 0.14% | 103 |
|
|
2013
Q3 | $262K | Buy |
+3,400
| New | +$238K | 0.12% | 114 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Ipswich Investment Management's CELG Position: Q4 2019 in Review
Ipswich Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,865 shares — an estimated $483K sold.
Ipswich Investment Management first reported a position in CELG in Q3 2013 and held it in 24 quarters. The position peaked at $3.86M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Ipswich Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Ipswich Investment Management sold 4,865 Celgene Corp shares in Q4 2019, an estimated $483K.
- Ipswich Investment Management first reported a position in Celgene Corp in Q3 2013 and held it in 24 quarters.
- Ipswich Investment Management's Celgene Corp position peaked at $3.86M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Ipswich Investment Management's 13F filing for Q4 2019, filed 8 Jan 2020.